ADC Therapeutics SA (ADCT) — Stock Score Summary

ADC Therapeutics SA (ADCT) has a MoatMap StockRank of 7/100 based on Quality (24/100), Value (49/100), and Momentum (14/100) factor scores. The current signal is STRONG SELL. ADC Therapeutics is a clinical-stage biotech focused on antibody-drug conjugates. It has high cash burn and binary clinical trial risks, failing our fundamental requirement for predictable cash-generating compounders.

ADC Therapeutics is a commercial-stage biotechnology company pioneering the development of highly targeted antibody-drug conjugates (ADCs) for oncology patients. The company's lead commercial product, Zynlonta, targets CD19-expressing hematological malignancies, establishing a strong foothold in the lymphoma market. Its competitive moat is anchored by a proprietary ADC technology platform that combines advanced linker chemistry with highly potent pyrrolobenzodiazepine (PBD) payloads.

Key Financial Metrics

Price$1.10
Market Cap$439M
P/E (Forward)-0.89
Price/Book-0.78
Return on Invested Capital-35.6%
Gross Margin-26.3%
Operating Margin-121.1%
Revenue Growth-9.5%
Free Cash Flow$-75M

ADC Therapeutics SA operates in the Biotechnology industry, part of the Healthcare sector (Switzerland).

Frequently Asked Questions

What is ADC Therapeutics SA’s (ADCT) StockRank?
MoatMap’s StockRank for ADC Therapeutics SA (ADCT) is 7/100, with a Strong Sell signal. It is a composite of Quality (24), Value (49), and Momentum (14) factor ranks across MoatMap’s 19,000+ stock universe.
Does ADC Therapeutics SA have an economic moat?
ADC Therapeutics SA (ADCT) has a Quality factor score of 24/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is ADC Therapeutics SA a buy, hold, or sell?
MoatMap’s current signal for ADC Therapeutics SA (ADCT) is Strong Sell, based on a StockRank of 7/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is ADC Therapeutics SA in?
ADC Therapeutics SA (ADCT) operates in the Healthcare sector, specifically the Biotechnology industry (Switzerland).
Browse all ranked stocksADCT deep dive reportAI ChampionsHow we score stocksSense-check another stock